Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A Case-Study of Implementation of Improved Strategies for Prevention of Laboratory-acquired Brucellosis.

Castrodale LJ, Raczniak GA, Rudolph KM, Chikoyak L, Cox RS, Franklin TL, Traxler RM, Guerra M.

Saf Health Work. 2015 Dec;6(4):353-6. doi: 10.1016/j.shaw.2015.07.009. Epub 2015 Aug 11.

2.

A survey of knowledge, attitudes, and practices towards skin and soft tissue infections in rural Alaska.

Raczniak GA, Gaines J, Bulkow LR, Kinzer MH, Hennessy TW, Klejka JA, Bruce MG.

Int J Circumpolar Health. 2016 Feb 23;75:30603. doi: 10.3402/ijch.v75.30603. eCollection 2016.

3.

Supportive Care of the First 2 Ebola Virus Disease Patients at the Monrovia Medical Unit.

Wong KK, Perdue CL, Malia J, Kenney JL, Peng S, Gwathney JK, Raczniak GA; Monrovia Medical Unit.

Clin Infect Dis. 2015 Oct 1;61(7):e47-51. doi: 10.1093/cid/civ420. Epub 2015 May 28.

PMID:
26021993
4.

Case report: Co-infection of Rickettsia rickettsii and Streptococcus pyogenes: is fatal Rocky Mountain spotted fever underdiagnosed?

Raczniak GA, Kato C, Chung IH, Austin A, McQuiston JH, Weis E, Levy C, Carvalho Mda G, Mitchell A, Bjork A, Regan JJ.

Am J Trop Med Hyg. 2014 Dec;91(6):1154-5. doi: 10.4269/ajtmh.14-0437. Epub 2014 Oct 20.

5.

Hepatitis B virus antibody levels 7 to 9 years after booster vaccination in Alaska native persons.

Keck JW, Bulkow LR, Raczniak GA, Negus SE, Zanis CL, Bruce MG, Spradling PR, Teshale EH, McMahon BJ.

Clin Vaccine Immunol. 2014 Sep;21(9):1339-42. doi: 10.1128/CVI.00263-14. Epub 2014 Jul 23.

6.

Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children.

Raczniak GA, Thomas TK, Bulkow LR, Negus SE, Zanis CL, Bruce MG, Spradling PR, Teshale EH, McMahon BJ.

Vaccine. 2013 Apr 19;31(17):2152-5. doi: 10.1016/j.vaccine.2013.02.048. Epub 2013 Mar 5.

7.

Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series.

Raczniak GA, Bulkow LR, Bruce MG, Zanis CL, Baum RL, Snowball MM, Byrd KK, Sharapov UM, Hennessy TW, McMahon BJ.

J Infect Dis. 2013 Feb 1;207(3):493-6. doi: 10.1093/infdis/jis710. Epub 2012 Nov 29.

8.

An outbreak of suspected cutaneous leishmaniasis in Ghana: lessons learnt and preparation for future outbreaks.

Kweku MA, Odoom S, Puplampu N, Desewu K, Nuako GK, Gyan B, Raczniak G, Kronmann KC, Koram K, Botero S, Boakye D, Akuffo H.

Glob Health Action. 2011;4. doi: 10.3402/gha.v4i0.5527. Epub 2011 Jul 13. Review.

9.

Evidence for a new species of Leishmania associated with a focal disease outbreak in Ghana.

Villinski JT, Klena JD, Abbassy M, Hoel DF, Puplampu N, Mechta S, Boakye D, Raczniak G.

Diagn Microbiol Infect Dis. 2008 Mar;60(3):323-7. Epub 2007 Nov 26.

PMID:
18031968
10.

Short report: ITS-1 DNA sequence confirmation of Leishmania major as a cause of cutaneous leishmaniasis from an outbreak focus in the Ho district, southeastern Ghana.

Fryauff DJ, Hanafi HA, Klena JD, Hoel DF, Appawu M, Rogers W, Puplampu N, Odoom S, Kweku M, Koram K, Wilson MD, Raczniak G, Boakye D.

Am J Trop Med Hyg. 2006 Sep;75(3):502-4. No abstract available.

PMID:
16968929
11.

Protein synthesis in Escherichia coli with mischarged tRNA.

Min B, Kitabatake M, Polycarpo C, Pelaschier J, Raczniak G, Ruan B, Kobayashi H, Namgoong S, Söll D.

J Bacteriol. 2003 Jun;185(12):3524-6.

12.

Aminoacyl-tRNA synthesis: a postgenomic perspective.

Stathopoulos C, Ahel I, Ali K, Ambrogelly A, Becker H, Bunjun S, Feng L, Herring S, Jacquin-Becker C, Kobayashi H, Korencic D, Krett B, Mejlhede N, Min B, Nakano H, Namgoong S, Polycarpo C, Raczniak G, Rinehart J, Rosas-Sandoval G, Ruan B, Sabina J, Sauerwald A, Toogood H, Tumbula-Hansen D, Ibba M, Söll D.

Cold Spring Harb Symp Quant Biol. 2001;66:175-83. Review. No abstract available.

PMID:
12762020
13.

Bacterial genomics: potential for antimicrobial drug discovery.

Fritz B, Raczniak GA.

BioDrugs. 2002;16(5):331-7. Review.

PMID:
12408737
14.

Genomics and the evolution of aminoacyl-tRNA synthesis.

Ruan B, Ahel I, Ambrogelly A, Becker HD, Bunjun S, Feng L, Tumbula-Hansen D, Ibba M, Korencic D, Kobayashi H, Jacquin-Becker C, Mejlhede N, Min B, Raczniak G, Rinehart J, Stathopoulos C, Li T, Söll D.

Acta Biochim Pol. 2001;48(2):313-21. Review.

15.

A single amidotransferase forms asparaginyl-tRNA and glutaminyl-tRNA in Chlamydia trachomatis.

Raczniak G, Becker HD, Min B, Söll D.

J Biol Chem. 2001 Dec 7;276(49):45862-7. Epub 2001 Oct 3.

16.
17.

Genomics-based identification of targets in pathogenic bacteria for potential therapeutic and diagnostic use.

Raczniak G, Ibba M, Söll D.

Toxicology. 2001 Mar 7;160(1-3):181-9. Review.

PMID:
11246138
18.

The heterotrimeric Thermus thermophilus Asp-tRNA(Asn) amidotransferase can also generate Gln-tRNA(Gln).

Becker HD, Min B, Jacobi C, Raczniak G, Pelaschier J, Roy H, Klein S, Kern D, Söll D.

FEBS Lett. 2000 Jul 7;476(3):140-4.

19.

The integral membrane protein snl1p is genetically linked to yeast nuclear pore complex function.

Ho AK, Raczniak GA, Ives EB, Wente SR.

Mol Biol Cell. 1998 Feb;9(2):355-73.

Supplemental Content

Loading ...
Support Center